Concepedia

Author

Emily Clayton

Adelphi Group (United Kingdom)ORCID

Also Known As

E Clayton, E. B. Clayton, E. Bellis Clayton, E. Clayton, E.Bellis Clayton, Emily Clayton, Emma L. Clayton

37

Publications

714

Citations

12

H-Index

27

Concepts

All Affiliations

Adelphi Group (United Kingdom)University of LiverpoolRoyal Lancaster InfirmaryUniversity of SouthamptonUniversity of Oxford
EC

About

Emily Clayton is an author at Adelphi Group (United Kingdom) specializing in medicine, biomedical engineering, and virology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

82

2

Engineering

2

2

69

3

Biomedical Engineering

2

2

69

4

Health Sciences

1

1

13

5

Medical Laboratory Science

1

1

58

Emily Clayton

×

8

Publications

412

Citations

8

H-Index

YearCitations

Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study

Shelley Potter, Elizabeth J. Conroy, Ramsey I Cutress,

The Lancet Oncology

2019

188

Artificial Intelligence-Assisted Loop Mediated Isothermal Amplification (AI-LAMP) for Rapid Detection of SARS-CoV-2

Mohammed A. Rohaim, Emily Clayton, İrem Şahin,

Viruses

2020

58

Impact of next-generation hormonal agents on treatment patterns among patients with metastatic hormone-sensitive prostate cancer: a real-world study from the United States, five European countries and Japan

Andrea Leith, Amanda Ribbands, Jeri Kim,

BMC Urology

2022

44

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima Abbas,

The Lancet Diabetes & Endocrinology

2023

34

Real-World Treatment Patterns in Metastatic Castration-Resistant Prostate Cancer Across Europe (France, Germany, Italy, Spain, and the United Kingdom) and Japan

Andrea Leith, Jeri Kim, Amanda Ribbands,

Advances in Therapy

2022

33

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Saul N. Faust, Richard Haynes, Christine E. Jones,

The Lancet Child & Adolescent Health

2024

31

Reasons for oncologist and urologist treatment choice in metastatic castration-sensitive prostate cancer (mCSPC): A physician survey linked to patient chart reviews in the United States.

Stephen J. Freedland, Zachary Klaassen, Neeraj Agarwal,

Journal of Clinical Oncology

2022

13

Artificial Intelligence-Assisted Loop Mediated Isothermal Amplification (ai-LAMP) for Rapid and Reliable Detection of SARS-CoV-2

Mohammed A. Rohaim, Emily Clayton, İrem Şahin,

2020

11

Page 1